Lastly, the reduced expression of SOCS5 was found in T-ALL patients with KMT2A translocations and resulted in the upregulation of IL-7Rα expression levels and the activation of JAK-STAT signaling, thereby promoting T-ALL cell proliferation in vitro and in vivo [61]. This evidence concerns the gene SOCS5 and acute lymphoblastic leukemia.